Showing results (21-30 of 116) with videos related to

Sort By:
Pageof 12
BMC Infectious Diseases|April 5, 2012
Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in SpainSantiago Grau, Rafael de la Cámara, Francisco J Sabater, et al.
Diagnostic Microbiology and Infectious Disease|September 25, 2007
Fungemia due to Candida guilliermondii in a pediatric and adult population during a 12-year periodJavier Pemán, María Bosch, Emilia Cantón, et al.
Gastroenterologia Y Hepatologia|May 26, 2023
Chronic liver disease-associated severe thrombocytopenia in Spain: Results from a retrospective study using machine learning and natural language processingJose Luis Calleja-Panero, Rafael Esteban Mur, Isidro Jarque, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|September 27, 2017
Secondary thrombotic microangiopathy and eculizumab: A reasonable therapeutic optionElena Román, Santiago Mendizábal, Isidro Jarque, et al.
Journal of Health Economics and Outcomes Research|May 27, 2022
Cost Analysis of the Use of Voriconazole, Posaconazole and Micafungin in the Primary Prophylaxis of Invasive Fungal Infections in Recipients of Allogeneic Hematopoietic Stem Cell TransplantsSantiago Grau, Carlos Solano, Carol García-Vidal, et al.
Platelets|May 14, 2024
Real-life clinical practice in Spain in the setting of new drug availability for ITP treatment. A Delphi-based Spanish expert panel consensusTomás José González-López, Abelardo Bárez, Ángel Bernardo-Gutiérrez, et al.
International Journal of Hematology|September 19, 2007
A study of incidence and characteristics of infections in 476 patients from a single center undergoing autologous blood stem cell transplantationNoemí Puig, Javier de la Rubia, Isidro Jarque, et al.
Medical Mycology|June 2, 2022
Cytokine response as a biomarker for early diagnosis and outcome prediction of stem cell transplant recipients and acute leukemia patients with invasive aspergillosisPedro Puerta-Alcalde, Isabel Ruiz-Camps, Carlota Gudiol, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|April 3, 2013
Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azolesJavier De la Serna, Isidro Jarque, Javier López-Jiménez, et al.
BMC Pharmacology & Toxicology|September 26, 2014
Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and SpainHelmut Ostermann, Carlos Solano, Isidro Jarque, et al.
Pageof 12